Low-molecular weight human interleukin-1β antagonist discovered

Researchers described the detection of a human interleukin-1β antagonist with low molecular weight that disrupts interactions with the interleukin-1 receptor type I receptor.

Pharmacy benefits managers should be worried

Public awareness is rapidly intensifying about the harmful role pharmacy benefit managers (PBMs) play in driving up prescription drug costs and denying consumers access to

December 17, 2024

Brain-computer interface translates ALS patient’s brain activity into spoken words

Researchers successfully used a brain-computer interface to synthesize speech directly from brain activity in an ALS patient, achieving 80% word recognition accuracy by listeners, showcasing

May 9, 2024

EssilorLuxottica integrates tech into glasses to target hearing loss market

Dive Brief: Eyewear leader EssilorLuxottica has developed glasses that feature technology to help people with mild- to moderate-hearing loss. The glasses feature microphones, speakers and algorithms

January 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.